Accustem Sciences Inc. (ACUT)

OTCMKTS: ACUT · Delayed Price · USD

0.410

+0.010 (2.50%)

Jul 2, 2024, 3:23 PM EDT - Market closed

Accustem Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022
Net Income	-3.75
Depreciation & Amortization	0
Share-Based Compensation	0.13
Other Operating Activities	1.8
Operating Cash Flow	-1.81
Other Investing Activities	-0.01
Investing Cash Flow	-0.01
Common Stock Issued	2.68
Other Financing Activities	-0.12
Financing Cash Flow	2.55
Net Cash Flow	0.73
Free Cash Flow	-1.81
Free Cash Flow Per Share	-0.16

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.